Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
- PMID: 32255489
- PMCID: PMC7184449
- DOI: 10.1093/cid/ciaa394
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
Abstract
Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting in various concentrations. Pharmacokinetic studies are therefore needed to define the optimal dosing regimen.
Keywords: COVID-19; SARS-Cov2; hydroxychloroquine; intensive care; pharmacokinetic.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Does therapeutic drug monitoring of hydroxychloroquine improve treatment outcome in intensive care unit patients with COVID-19?Int J Clin Pract. 2021 Apr;75(4):e13894. doi: 10.1111/ijcp.13894. Int J Clin Pract. 2021. PMID: 33752299 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous